Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities

Federal funding opportunity RFA-FD-25-023 from Food and Drug Administration (Department of Health and Human Services).

Program funding history

Synopsis

Who can apply

• County governments
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Public housing authorities/Indian housing authorities
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Native American tribal governments (Federally recognized)
• City or township governments
• State governments
• Public and State controlled institutions of higher education
• Private institutions of higher education
• Independent school districts
• For profit organizations other than small businesses
• Native American tribal organizations (other than Federally recognized tribal governments)
• Special district governments
• Small businesses
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

1. Eligible Applicants Eligible Organizations Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations Small Businesses For-Profit Organizations (Other than Small Businesses) Local Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Federal Governments Eligible Agencies of the Federal Government U.S. Territory or Possession Other Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations N/A Foreign Organizations Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Required Registrations Applicant Organizations Applicant organizations must complete and maintain the following registrations as described in the How to Apply - Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. Failure to complete registrations in advance of a due date is not a valid reason for a late submission, please reference the HHS Grants Policy Statement for additional information System for Award Management (SAM)…

The official record

Similar grants

• Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities
  FOR-FD-25-023 · Food and Drug Administration
• Minor Use Minor Species Development of Drugs (R01)
  PAR-24-216 · Food and Drug Administration · closes January 29, 2027
• Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
  FOR-FD-24-003 · Food and Drug Administration
• Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
  FOR-FD-24-008 · Food and Drug Administration
• Minor Use Minor Species Development of Drugs (R01)
  FOR-FD-24-013 · Food and Drug Administration
• Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
  PAR-25-003 · Food and Drug Administration · closes April 1, 2027